Key result
Clinical risk scoring systems (SCORE, Framingham, ACC/AHA) had no diagnostic value for identifying the absence of coronary atherosclerosis or lesions >30% compared to CT angiography (p>0.05).
Why the study?
The study was conducted to compare CT coronary angiography findings with calculated risks of cardiovascular complications from common risk scales in asymptomatic patients.
Do cardiovascular risk scoring systems accurately predict coronary atherosclerosis compared to CT coronary angiography in asymptomatic patients?
Cross-Sectional (n=60)
Do cardiovascular risk scoring systems accurately predict coronary atherosclerosis compared to CT coronary angiography in asymptomatic patients?
p-value: p=>0.05
Risk scales may misclassify asymptomatic patients; leaves open validation against CT angiography in prospective cohorts.
Objective. To compare the results of CT coronary angiography and risk of cardiovascular complications calculated by using of the most common instruments (scales) in asymptomatic patients. Material and methods. The study included 60 patients (35% men). The cut-off point was data of direct coronary artery imaging using 640-slice CT. In relation to these data, we analyzed distribution of calculated risks of cardiovascular accidents in patients with patent coronary arteries. Risks were determined using the Score, ACC/AHA, Framingham and MESA scales. ROC analysis was applied to assess sensitivity and specificity of these scales, as well as coronary calcium index in identifying severity of coronary artery lesion. Results. Distribution of cardiovascular risks among patients without coronary atherosclerosis showed overestimation of risks when using the SCORE and Framingham scales (+33.33% and +52.38%) and underestimation when using the ACC/AHA and MESA scales (–33.33% and –9.52%). According to ROC analysis, SCORE, Framingham and ACC/AHA scales had no diagnostic value if the cut-off point was the absence of coronary atherosclerosis (p>0.05) and atherosclerotic vascular lesion exceeds 30% (p>0.05). Conclusion. The latest clinical guidelines show that sufficient experience has been accumulated to include CT coronary angiography in routine clinical practice. Our data point to the need for rational use of coronary calcium index, while CT coronary angiography in asymptomatic patients requires prospective studies despite high diagnostic sensitivity.
No takes yet. Share an insight, caveat, or question.
Rozhkov et al. (2023) conducted a cross-sectional in Asymptomatic cardiovascular risk (n=60). Clinical risk scoring systems (SCORE, ACC/AHA, Framingham, MESA) vs. CT coronary angiography was evaluated on Diagnostic value (sensitivity and specificity) for identifying absence of coronary atherosclerosis or lesions >30% (p=>0.05). Clinical risk scoring systems (SCORE, Framingham, ACC/AHA) had no diagnostic value for identifying the absence of coronary atherosclerosis or lesions >30% compared to CT angiography (p>0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: